Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Tylenol Precise is Kenvue’s First US Product Launch Since Its Publicly Traded Status - Happi
Company News, New Products

Tylenol Precise is Kenvue’s First US Product Launch Since Its Publicly Traded Status

Gel cream topical offers maximum strength lidocaine without a prescription.

Kenvue, a Happi Top 50 Company, has announced its first US product launch since it became publicly traded. 
 
Tylenol Precise builds on “decades of science innovation brought about by consumer-led insights,” said the company.
 
Tylenol created a gel cream topical to provide maximum strength lidocaine (4%) without a prescription. The massaging rollerball applicator delivers targeted pain relief.

The development of this product also addresses a need for the brand—it revealed 73% of Tylenol users also apply topicals for pain relief.

 

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters